Vestor Capital LLC Acquires 15,036 Shares of McKesson Corporation $MCK

Vestor Capital LLC grew its stake in McKesson Corporation (NYSE:MCK) by 845.7% during the 1st quarter, HoldingsChannel reports. The firm owned 16,814 shares of the company’s stock after acquiring an additional 15,036 shares during the quarter. Vestor Capital LLC’s holdings in McKesson were worth $14,550,000 at the end of the most recent reporting period.

Other institutional investors have also bought and sold shares of the company. University of Texas Texas AM Investment Management Co. bought a new position in shares of McKesson during the fourth quarter valued at $25,000. Swiss RE Ltd. acquired a new position in McKesson in the fourth quarter valued at about $26,000. State of Wyoming bought a new stake in McKesson during the second quarter worth about $29,000. Kingdom Financial Group LLC. acquired a new stake in shares of McKesson during the fourth quarter worth approximately $33,000. Finally, Birchwood Financial Partners Inc. acquired a new position in shares of McKesson in the 4th quarter worth approximately $33,000. Institutional investors and hedge funds own 85.07% of the company’s stock.

Key Headlines Impacting McKesson

Here are the key news stories impacting McKesson this week:

• Positive Sentiment: McKesson continues to benefit from expectations for earnings growth. Its latest reported quarter exceeded EPS estimates, and management’s fiscal 2027 outlook calls for earnings of $43.80–$44.60 per share. McKesson earnings expected to grow
• Neutral Sentiment: McKesson’s chief legal officer is leaving to take the same role at luxury home-furnishings company RH. The move is not necessarily an operating concern, but executive turnover may attract investor attention. RH hires McKesson chief legal officer
• Negative Sentiment: A Zacks preview said McKesson lacks the combination of favorable earnings expectations and estimate-revision momentum that typically signals a likely earnings beat. That caution may have pressured the stock ahead of results, particularly after its strong run toward its 52-week high. McKesson earnings preview
• Negative Sentiment: The latest market recap noted that McKesson declined while the broader market advanced, indicating relative weakness rather than a sector-wide healthcare selloff. Investors appear focused on whether upcoming results can justify the company’s elevated valuation. McKesson stock market recap

McKesson Stock Performance

Shares of McKesson stock opened at $867.05 on Friday. The firm has a fifty day moving average of $788.86 and a two-hundred day moving average of $840.10. The stock has a market capitalization of $101.51 billion, a price-to-earnings ratio of 22.54, a PEG ratio of 1.46 and a beta of 0.31. McKesson Corporation has a 52 week low of $637.00 and a 52 week high of $999.00.

McKesson (NYSE:MCK) last posted its quarterly earnings results on Thursday, May 7th. The company reported $11.69 earnings per share (EPS) for the quarter, topping the consensus estimate of $11.56 by $0.13. McKesson had a negative return on equity of 345.35% and a net margin of 1.18%.The business had revenue of $96.30 billion for the quarter, compared to analyst estimates of $101.35 billion. During the same period last year, the company earned $10.12 EPS. The firm’s revenue was up 6.0% on a year-over-year basis. McKesson has set its FY 2027 guidance at 43.800-44.600 EPS. As a group, research analysts forecast that McKesson Corporation will post 44.28 EPS for the current fiscal year.

McKesson Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, October 1st. Stockholders of record on Tuesday, September 1st will be paid a $0.94 dividend. This is a boost from McKesson’s previous quarterly dividend of $0.82. The ex-dividend date of this dividend is Tuesday, September 1st. This represents a $3.76 dividend on an annualized basis and a dividend yield of 0.4%. McKesson’s dividend payout ratio (DPR) is currently 9.77%.

Analysts Set New Price Targets

MCK has been the topic of a number of recent analyst reports. Weiss Ratings lowered McKesson from a “buy (b)” rating to a “buy (b-)” rating in a research note on Tuesday, July 7th. UBS Group upped their price target on shares of McKesson from $1,000.00 to $1,050.00 and gave the stock a “buy” rating in a research report on Friday, May 8th. William Blair initiated coverage on shares of McKesson in a research note on Tuesday, April 28th. They issued an “outperform” rating for the company. Barclays decreased their price target on shares of McKesson from $1,050.00 to $925.00 and set an “overweight” rating on the stock in a research note on Wednesday, June 10th. Finally, JPMorgan Chase & Co. dropped their price objective on shares of McKesson from $1,107.00 to $1,015.00 and set an “overweight” rating for the company in a research report on Friday, May 8th. Fourteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $962.67.

Insider Buying and Selling

In related news, CAO Napoleon B. Rutledge, Jr. sold 133 shares of McKesson stock in a transaction that occurred on Friday, June 5th. The shares were sold at an average price of $764.00, for a total transaction of $101,612.00. Following the transaction, the chief accounting officer owned 632 shares of the company’s stock, valued at $482,848. This trade represents a 17.39% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michele Lau sold 3,550 shares of the business’s stock in a transaction that occurred on Tuesday, May 26th. The shares were sold at an average price of $761.09, for a total transaction of $2,701,869.50. Following the transaction, the executive vice president owned 3,247 shares of the company’s stock, valued at approximately $2,471,259.23. This represents a 52.23% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 28,748 shares of company stock valued at $22,262,035. Insiders own 0.06% of the company’s stock.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.